Advances in Treating High Risk MDS and AML | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Advances in Treating High Risk MDS and AML

Presenter(s): 
Topic(s): 
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Tue, 10/13/2020 - 8:00pm (EDT)

Dr. Mims provides an overview of the latest treatment options in pipeline for High-Risk MDS and AML patients including several promising clinical trials that may be suitable for patients.